Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Estrogen can temporarily slow down hair growth but this can be reversed.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Hormonal therapies are safe and effective for treating adult women's acne.